News

The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has ...
The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety of mRNA technology, despite an extensive history of testing. The post HHS ...
WASHINGTON — mRNA, a Nobel-winning technology harnessed by Trump officials to create Covid shots in record time, is becoming ...
BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...
The negative sentiment towards the S&P 500 Health Care Index Sector (NYSEARCA:XLV) softened in May as average short interest ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump administration vs. mRNA vaccines ...
The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...
The Trump administration is waging war against mRNA vaccines despite President Donald Trump having called them the “gold standard” when his admin rolled out the COVID shots […] ...
BioNTech is buying fellow German mRNA vaccine developer CureVac in an all-stock transaction that values the acquired biotech ...
Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.
The tantalising development has been reported by researchers at the Peter Doherty Institute for Infection and Immunity in ...
BioNTech has agreed to buy another specialist in mRNA-based vaccines and therapeutics, fellow German biotech CureVac, in an ...